Shafer RW - Search Results

1

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.

Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW. Tang MW, et al. Among authors: shafer rw. J Infect Dis. 2013 Jun 15;207 Suppl 2(Suppl 2):S70-7. doi: 10.1093/infdis/jit114. J Infect Dis. 2013. PMID: 23687292 Free PMC article.

2

HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.

Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Aguiniga E, Halpern J, Merigan TC. Kozal MJ, et al. Among authors: shafer rw. J Acquir Immune Defic Syndr (1988). 1994 Aug;7(8):832-8. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7517448

3

Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.

Kozal MJ, Kroodsma K, Winters MA, Shafer RW, Efron B, Katzenstein DA, Merigan TC. Kozal MJ, et al. Among authors: shafer rw. Ann Intern Med. 1994 Aug 15;121(4):263-8. doi: 10.7326/0003-4819-121-4-199408150-00005. Ann Intern Med. 1994. PMID: 7518658

4

Drug resistance and heterogeneous long-term virologic responses of human immunodeficiency virus type 1-infected subjects to zidovudine and didanosine combination therapy. The AIDS Clinical Trials Group 143 Virology Team.

Shafer RW, Iversen AK, Winters MA, Aguiniga E, Katzenstein DA, Merigan TC. Shafer RW, et al. J Infect Dis. 1995 Jul;172(1):70-8. doi: 10.1093/infdis/172.1.70. J Infect Dis. 1995. PMID: 7541064 Clinical Trial.

5

A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients.

Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Merigan TC. Kozal MJ, et al. Among authors: shafer rw. J Infect Dis. 1993 Mar;167(3):526-32. doi: 10.1093/infdis/167.3.526. J Infect Dis. 1993. PMID: 7680058

6

Clarification of a method to reverse transcribe human immunodeficiency virus RNA.

Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Merigan TC. Kozal MJ, et al. Among authors: shafer rw. J Infect Dis. 1995 Apr;171(4):1072. doi: 10.1093/infdis/171.4.1072. J Infect Dis. 1995. PMID: 7706796 No abstract available.

7

Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.

Holodniy M, Katzenstein D, Winters M, Montoya J, Shafer R, Kozal M, Ragni M, Merigan TC. Holodniy M, et al. J Acquir Immune Defic Syndr (1988). 1993 Apr;6(4):366-9. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8095981

8

Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates.

Shafer RW, Kozal MJ, Katzenstein DA, Lipil WH, Johnstone IF, Merigan TC. Shafer RW, et al. J Virol Methods. 1993 Mar;41(3):297-310. doi: 10.1016/0166-0934(93)90019-n. J Virol Methods. 1993. PMID: 8097199

9

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

Shafer RW, Kozal MJ, Winters MA, Iversen AK, Katzenstein DA, Ragni MV, Meyer WA 3rd, Gupta P, Rasheed S, Coombs R, et al. Shafer RW, et al. J Infect Dis. 1994 Apr;169(4):722-9. doi: 10.1093/infdis/169.4.722. J Infect Dis. 1994. PMID: 8133086 Clinical Trial.

10

A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolates.

Jellinger RM, Shafer RW, Merigan TC. Jellinger RM, et al. Among authors: shafer rw. J Infect Dis. 1997 Mar;175(3):561-6. doi: 10.1093/infdis/175.3.561. J Infect Dis. 1997. PMID: 9041326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters